• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有症状的阿尔茨海默病患者中异常的突触PTEN可能将突触抑制与网络功能障碍联系起来。

Aberrant Synaptic PTEN in Symptomatic Alzheimer's Patients May Link Synaptic Depression to Network Failure.

作者信息

Díaz González Marta, Buberman Assaf, Morales Miguel, Ferrer Isidro, Knafo Shira

机构信息

Department of Physiology and Cell Biology, Faculty of Health Sciences, The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Instituto Biofisika (UPV/EHU, CSIC), University of the Basque Country, Leioa, Spain.

出版信息

Front Synaptic Neurosci. 2021 May 11;13:683290. doi: 10.3389/fnsyn.2021.683290. eCollection 2021.

DOI:10.3389/fnsyn.2021.683290
PMID:34045952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8144462/
Abstract

In Alzheimer's disease (AD), Amyloid β (Aβ) impairs synaptic function by inhibiting long-term potentiation (LTP), and by facilitating long-term depression (LTD). There is now evidence from AD models that Aβ provokes this shift toward synaptic depression by triggering the access to and accumulation of PTEN in the postsynaptic terminal of hippocampal neurons. Here we quantified the PTEN in 196,138 individual excitatory dentate gyrus synapses from AD patients at different stages of the disease and from controls with no neuropathological findings. We detected a gradual increase of synaptic PTEN in AD brains as the disease progresses, in conjunction with a significant decrease in synaptic density. The synapses that remain in symptomatic AD patients are more likely to be smaller and exhibit fewer AMPA receptors (AMPARs). Hence, a high Aβ load appears to strongly compromise human hippocampal synapses, as reflected by an increase in PTEN, inducing a loss of AMPARs that may eventually provoke synaptic failure and loss.

摘要

在阿尔茨海默病(AD)中,淀粉样β蛋白(Aβ)通过抑制长时程增强(LTP)和促进长时程抑制(LTD)来损害突触功能。目前来自AD模型的证据表明,Aβ通过触发海马神经元突触后终末中PTEN的进入和积累,促使这种向突触抑制的转变。在此,我们对来自不同疾病阶段的AD患者以及无神经病理学发现的对照的196,138个单个兴奋性齿状回突触中的PTEN进行了定量。我们检测到随着疾病进展,AD大脑中突触PTEN逐渐增加,同时突触密度显著降低。有症状的AD患者中残留的突触更可能较小且表现出较少的α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPARs)。因此,高Aβ负荷似乎会严重损害人类海马突触,这表现为PTEN增加,导致AMPARs丢失,最终可能引发突触功能障碍和丧失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/33a30f1528b4/fnsyn-13-683290-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/4a69aa9a5683/fnsyn-13-683290-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/c0028d32d08f/fnsyn-13-683290-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/068404e8134f/fnsyn-13-683290-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/4c36e77cafb0/fnsyn-13-683290-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/33a30f1528b4/fnsyn-13-683290-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/4a69aa9a5683/fnsyn-13-683290-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/c0028d32d08f/fnsyn-13-683290-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/068404e8134f/fnsyn-13-683290-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/4c36e77cafb0/fnsyn-13-683290-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4224/8144462/33a30f1528b4/fnsyn-13-683290-g005.jpg

相似文献

1
Aberrant Synaptic PTEN in Symptomatic Alzheimer's Patients May Link Synaptic Depression to Network Failure.有症状的阿尔茨海默病患者中异常的突触PTEN可能将突触抑制与网络功能障碍联系起来。
Front Synaptic Neurosci. 2021 May 11;13:683290. doi: 10.3389/fnsyn.2021.683290. eCollection 2021.
2
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.非纤维状β淀粉样蛋白通过靶向突触后AMPA受体减弱新皮层2/3层兴奋性突触处的尖峰时间依赖性突触增强。
Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x.
3
Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3.可溶性淀粉样β蛋白在大鼠海马体中增强长时程抑制作用是由代谢型谷氨酸受体介导的,涉及 p38MAPK、STEP 和 caspase-3 的激活。
Neuroscience. 2013 Dec 3;253:435-43. doi: 10.1016/j.neuroscience.2013.08.054. Epub 2013 Sep 5.
4
The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat.慢性刺激 7 型血清素受体对淀粉样β蛋白处理大鼠识别、被动回避记忆、海马长时程增强和神经元凋亡的影响。
Psychopharmacology (Berl). 2018 May;235(5):1513-1525. doi: 10.1007/s00213-018-4862-3. Epub 2018 Apr 10.
5
Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.星形胶质细胞谷氨酸能转运体参与β淀粉样蛋白诱导的突触功能障碍。
Brain Res. 2018 Jan 1;1678:129-137. doi: 10.1016/j.brainres.2017.10.011. Epub 2017 Oct 21.
6
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.解析具有生物活性的人源 AD 脑可溶性 Aβ 的突触功能障碍,为阿尔茨海默病提供新的治疗途径。
Acta Neuropathol Commun. 2018 Nov 8;6(1):121. doi: 10.1186/s40478-018-0626-x.
7
β-Amyloid triggers aberrant over-scaling of homeostatic synaptic plasticity.β-淀粉样蛋白引发了稳态突触可塑性的异常过度扩张。
Acta Neuropathol Commun. 2016 Dec 13;4(1):131. doi: 10.1186/s40478-016-0398-0.
8
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.寡聚淀粉样β蛋白诱导的阿尔茨海默病突触功能障碍。
Mol Neurodegener. 2014 Nov 14;9:48. doi: 10.1186/1750-1326-9-48.
9
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.阿尔茨海默病风险因素 Pyk2 介导淀粉样β诱导的突触功能障碍和丧失。
J Neurosci. 2019 Jan 23;39(4):758-772. doi: 10.1523/JNEUROSCI.1873-18.2018. Epub 2018 Dec 5.
10
Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.在阿尔茨海默病PS2APP小鼠模型早期病理过程中,GluN2B N-甲基-D-天冬氨酸受体功能及突触可塑性的改变
Neurobiol Dis. 2015 Feb;74:254-62. doi: 10.1016/j.nbd.2014.11.017. Epub 2014 Dec 4.

引用本文的文献

1
Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell Plasticity.迟发性阿尔茨海默病患者的神经干细胞表现出 Sirtuin 1 的调节异常,这取决于载脂蛋白 E,表明干细胞的可塑性受到干扰。
Mol Neurobiol. 2024 Mar;61(3):1562-1579. doi: 10.1007/s12035-023-03633-z. Epub 2023 Sep 20.
2
Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males.与男性相比,APOE基因分型对阿尔茨海默病女性脑脊液细胞外囊泡中微小RNA含量的差异影响。
Front Cell Dev Biol. 2022 Apr 27;10:864022. doi: 10.3389/fcell.2022.864022. eCollection 2022.

本文引用的文献

1
Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.阿尔茨海默病中海马 CA1 区突触组织的三维分析。
Brain. 2021 Mar 3;144(2):553-573. doi: 10.1093/brain/awaa406.
2
Preformulation Studies of a Stable PTEN-PDZ Lipopeptide Able to Cross an In Vitro Blood-Brain-Barrier Model as a Potential Therapy for Alzheimer's Disease.PTEN-PDZ 脂肽前体制备研究,该脂肽能够穿过体外血脑屏障模型,有望成为阿尔茨海默病的潜在治疗方法。
Pharm Res. 2020 Sep 4;37(10):183. doi: 10.1007/s11095-020-02915-8.
3
Dentate gyrus circuits for encoding, retrieval and discrimination of episodic memories.
齿状回回路用于编码、检索和区分情景记忆。
Nat Rev Neurosci. 2020 Mar;21(3):153-168. doi: 10.1038/s41583-019-0260-z. Epub 2020 Feb 10.
4
Amyloid-β oligomers suppress subunit-specific glutamate receptor increase during LTP.淀粉样β寡聚体在长时程增强过程中抑制亚基特异性谷氨酸受体增加。
Alzheimers Dement (N Y). 2019 Nov 20;5:797-808. doi: 10.1016/j.trci.2019.10.003. eCollection 2019.
5
FDA position statement "Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry".美国食品药品监督管理局立场声明《早期阿尔茨海默病:治疗药物研发,行业指南》
Alzheimers Dement (N Y). 2019 Jan 10;5:13-19. doi: 10.1016/j.trci.2018.11.004. eCollection 2019.
6
PTEN Activity Defines an Axis for Plasticity at Cortico-Amygdala Synapses and Influences Social Behavior.PTEN 活性定义了皮质-杏仁核突触可塑性的一个轴,并影响社会行为。
Cereb Cortex. 2020 Mar 21;30(2):505-524. doi: 10.1093/cercor/bhz103.
7
Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.经颅磁刺激可预测阿尔茨海默病患者的认知能力下降。
J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1237-1242. doi: 10.1136/jnnp-2017-317879. Epub 2018 Jul 21.
8
Alzheimer's disease drug development pipeline: 2018.2018年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2018 May 3;4:195-214. doi: 10.1016/j.trci.2018.03.009. eCollection 2018.
9
Preferential Targeting of Lateral Entorhinal Inputs onto Newly Integrated Granule Cells.外侧内嗅皮层输入优先靶向新整合的颗粒细胞。
J Neurosci. 2018 Jun 27;38(26):5843-5853. doi: 10.1523/JNEUROSCI.1737-17.2018. Epub 2018 May 23.
10
Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.阿尔茨海默病治疗面临的挑战:来自记忆缺陷之外新机制的见解。
Front Neurosci. 2018 Feb 6;12:37. doi: 10.3389/fnins.2018.00037. eCollection 2018.